نتائج البحث - Neema Navai

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor

    Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor حسب Anthony J. Saporita, Qiuheng Zhang, Neema Navai, Zehra Dincer, Junghyun Hahn, Xiaoyan Cai, Zhou Wang

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin

    Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Ba... حسب Niyati Lobo, Patrick J. Hensley, Kelly K. Bree, Graciela M. Nogueras‐González, Neema Navai, Colin P. Dinney, Richard Sylvester, Ashish M. Kamat

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes

    Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes حسب Michael Metcalfe, Gavin Wagenheim, Lianchun Xiao, John Papadopoulos, Neema Navai, John W. Davis, José A. Karam, Ashish M. Kamat, Christopher G. Wood, Colin P. Dinney, Surena F. Matin

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells

    The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells حسب Mai Tran, Woonyoung Choi, Matthew Wszolek, Neema Navai, I-Ling C. Lee, Giovanni Nitti, Sijin Wen, Elsa R. Flores, Arlene O. Siefker‐Radtke, Bogdan Czerniak, Colin P. Dinney, Michelle Barton, David J. McConkey

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

    Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy حسب Stephen H. Culp, Rian J. Dickstein, H. Barton Grossman, Shanna Pretzsch, Sima P. Porten, Siamak Daneshmand, Jie Cai, Susan Groshen, Arlene O. Siefker‐Radtke, Randall E. Millikan, Bogdan Czerniak, Neema Navai, Matthew Wszolek, Ashish M. Kamat, Colin P. Dinney

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

    Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer حسب Colin P. Dinney, Mark B. Fisher, Neema Navai, Michael A. O’Donnell, David L. Cutler, Alice Abraham, Sophia L. Young, Beth Hutchins, Maria Caceres, Narendra S. Kishnani, George Sode, Constance Cullen, Guangcheng Zhang, H. Barton Grossman, Ashish M. Kamat, Marshall Gonzales, Michael Kincaid, Nancy Ainslie, Daniel C. Maneval, Matthew Wszolek, William F. Benedict

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Frequent truncating mutations of STAG2 in bladder cancer

    Frequent truncating mutations of STAG2 in bladder cancer حسب David A. Solomon, Jung-Sik Kim, Jolanta Bondaruk, Shahrokh F. Shariat, Zeng-Feng Wang, Abdel Elkahloun, Tomoko Ozawa, Julia Gerard, Dazhong Zhuang, Shizhen Zhang, Neema Navai, Arlene O. Siefker‐Radtke, Joanna J. Phillips, Brian D. Robinson, Mark A. Rubin, Björn Volkmer, Richard E. Hautmann, R. Küfer, Pancras C.W. Hogendoorn, George J. Netto, Dan Theodorescu, C. David James, Bogdan Czerniak, Markku Miettinen, Todd Waldman

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

    Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma حسب Jianjun Gao, Neema Navai, Omar Alhalabi, Arlene O. Siefker‐Radtke, Matthew T. Campbell, Rebecca S. Tidwell, Charles C. Guo, Ashish M. Kamat, Surena F. Matin, John C. Araujo, Amishi Y. Shah, Pavlos Msaouel, Paul G. Corn, Jianbo Wang, John Papadopoulos, Shalini S. Yadav, Jorge Blando, Fei Duan, Sreyashi Basu, Wenbin Liu, Yu Shen, Yuwei Zhang, Marc Macaluso, Ying Wang, Jianfeng Chen, Jianhua Zhang, P. Andrew Futreal, Colin P. Dinney, James P. Allison, Sangeeta Goswami, Padmanee Sharma

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: